NiclosaMide-13C6 hydrate (see Data Sheet)
Names
[ CAS No. ]:
1325808-64-7
[ Name ]:
NiclosaMide-13C6 hydrate (see Data Sheet)
[Synonym ]:
5-Chloro-N-[2-chloro-4-nitro(13C6)phenyl]-2-hydroxybenzamide
Benzamide, 5-chloro-N-(2-chloro-4-nitrophenyl-1,2,3,4,5,6-13C6)-2-hydroxy-
Biological Activity
[Description]:
Niclosamide-13C6 is the 13C6 labeled Niclosamide. Niclosamide (BAY2353) is an orally bioavailable chlorinated salicylanilide, with anthelmintic and potential antineoplastic activity. Niclosamide (BAY2353) inhibits STAT3 with IC50 of 0.25 μM in HeLa cells and inhibits DNA replication in a cell-free assay.
[Related Catalog]:
[In Vitro]
Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1].
[References]
[1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-223.
[2]. Ren, X., et al., Identification of niclosamide as a new small-molecule inhibitor of the STAT3 signaling pathway. ACS Medicinal Chemistry Letters, 2010. 1(9): p. 454-459.
[3]. Wu CJ, et al. Inhibition of severe acute respiratory syndrome coronavirus replication by niclosamide. Antimicrob Agents Chemother. 2004 Jul;48(7):2693-6.
[4]. Chen, M., et al., The anti-helminthic niclosamide inhibits Wnt/Frizzled1 signaling. Biochemistry, 2009. 48(43): p. 10267-74.
[5]. Jin, Y., et al. Antineoplastic mechanisms of niclosamide in acute myelogenous leukemia stem cells: inactivation of the NF-kappaB pathway and generation of reactive oxygen species. Cancer Res, 2010. 70(6): p. 2516-27.
Chemical & Physical Properties
[ Density]:
1.6±0.1 g/cm3
[ Molecular Formula ]:
C713C6H8Cl2N2O4
[ Molecular Weight ]:
333.076
[ Exact Mass ]:
332.006256
[ Index of Refraction ]:
1.709
Safety Information
[ Hazard Codes ]:
Xi
[ Risk Phrases ]:
38-41
[ Safety Phrases ]:
26-39